Journal of Neuroimmune Pharmacology

J Neuroimmune Pharmacol

1557-1890

1557-1904

Therapeutic Area

Clinical Pharmacology, Cytology/Cell Biology, Immunology, Neuromuscular Disorders, Neuropsychology, Neuroscience, Pharmacology, Vaccines/Vaccinology

Cardiologists, Clinical Microbiologists, Clinical Pharmacologists, Clinicians, Immunologists, Neurologists, Neuroscientists, Pharmaco-Epidemiologists, Pharmacologists, Spinal Cord Lesions/Research

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

Society on NeuroImmune Pharmacology (SNIP)

Springer Science and Business Media

Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines